PAM
CRL icon

Paradigm Asset Management’s Charles River Laboratories CRL Stock Holding History

Paradigm Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.4K Hold
176
– – 0.01% 399
2025
Q4 		$35.1K Hold
176
– – 0.01% 439
2025
Q3 		$27.5K Hold
176
– – 0.01% 438
2025
Q2 		$26.7K Hold
176
– – 0.01% 445
2025
Q1 		$26.5K Hold
176
– – 0.01% 457
2024
Q4 		$32.5K Hold
176
– – 0.01% 437
2024
Q3 		$34.7K Hold
176
– – 0.01% 431
2024
Q2 		$36.4K Hold
176
– – 0.01% 432
2024
Q1 		$47.7K Hold
176
– – 0.01% 430
2023
Q4 		$41.6K Hold
176
– – 0.01% 444
2023
Q3 		$34.5K Hold
176
– – 0.01% 484
2023
Q2 		$37K Hold
176
– – 0.01% 437
2023
Q1 		$35.5K Hold
176
– – 0.01% 428
2022
Q4 		$38.4K Sell
176
-2,600
-94% -$568K 0.01% 436
2022
Q3 		$546K Hold
2,776
– – 0.18% 219
2022
Q2 		$594K Hold
2,776
– – 0.18% 218
2022
Q1 		$788K Hold
2,776
– – 0.21% 175
2021
Q4 		$1.05M Buy
2,776
+176
+7% +$68.4K 0.26% 145
2021
Q3 		$1.07M Sell
2,600
-100
-4% -$41.5K 0.29% 120
2021
Q2 		$999K Hold
2,700
– – 0.26% 157
2021
Q1 		$783K Sell
2,700
-100
-4% -$27.8K 0.21% 214
2020
Q4 		$700K Buy
+2,800
New +$667K 0.2% 204
2016
Q3 		– Sell
-1,600
Closed -$132K – 676
2016
Q2 		$132K Hold
1,600
– – 0.02% 374
2016
Q1 		$122K Sell
1,600
-3,100
-66% -$229K 0.02% 389
2015
Q4 		$378K Buy
+4,700
New +$339K 0.07% 279

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Paradigm Asset Management's CRL Position: Q1 2026 in Review

Paradigm Asset Management held its Charles River Laboratories (CRL) position steady in Q1 2026 at 176 shares worth $30.4K. The position accounts for 0.01% of the portfolio, ranked #399.

Paradigm Asset Management first reported a position in CRL in Q4 2015 and has held it in 25 quarters since. The position peaked at $1.07M in Q3 2021. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Paradigm Asset Management held 176 shares of Charles River Laboratories worth $30.4K as of Q1 2026.
  • Paradigm Asset Management left its Charles River Laboratories share count unchanged in Q1 2026.
  • Charles River Laboratories made up 0.01% of Paradigm Asset Management's portfolio in Q1 2026, its #399 holding.
  • Paradigm Asset Management first reported a position in Charles River Laboratories in Q4 2015 and has held it in 25 quarters since.
  • Paradigm Asset Management's Charles River Laboratories position peaked at $1.07M in Q3 2021.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Paradigm Asset Management's 13F filing for Q1 2026, filed 12 May 2026.